retatrutide phase 2 trial obesity Weight loss with as compared to currently licenced Retatrutide Phase 2: Type 2
Description
Start your journey to a healthier you today.
Who is the drug intended to treat
#GLP1meals #ChickfilAHealthy
Bruising at injection sites is a common side effect of semaglutide therapy, occurring in approximately 10-15% of patients during their first month
I reported it to Meta and the group has now been removed
